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abstract
 
KvLQT1 is a voltage-gated potassium channel expressed in cardiac cells that is critical for myocardial
repolarization. When expressed alone in heterologous expression systems, KvLQT1 channels exhibit a rapidly ac-
tivating potassium current that slowly deactivates. MinK, a 129 amino acid protein containing one transmem-
brane-spanning domain modulates KvLQT1, greatly slowing activation, increasing current amplitude, and remov-
ing inactivation. Using deletion and chimeric analysis, we have examined the structural determinants of MinK ef-
fects on gating modulation and subunit association. Coexpression of KvLQT1 with a MinK COOH-terminus
 
deletion mutant (MinK 
 
D
 
Cterm) in 
 
Xenopus
 
 oocytes resulted in a rapidly activated potassium current closely re-
sembling currents recorded from oocytes expressing KvLQT1 alone, indicating that this region is necessary for
modulation. To determine whether MinK 
 
D
 
Cterm was associated with KvLQT1, a functional tag (G55C) that con-
fers susceptibility to partial block by external cadmium was engineered into the transmembrane domain of MinK
 
D
 
Cterm. Currents derived from coexpression of KvLQT1 with MinK 
 
D
 
Cterm were cadmium sensitive, suggesting
that MinK 
 
D
 
Cterm does associate with KvLQT1, but does not modulate gating. To determine which MinK regions
 
are sufﬁcient for KvLQT1 association and modulation, chimeras were generated between MinK and the Na
 
1
 
 chan-
nel 
 
b
 
1 subunit. Chimeras between MinK and 
 
b
 
1 could only modulate KvLQT1 if they contained both the MinK
transmembrane domain and COOH terminus, suggesting that the MinK COOH terminus alone is not sufﬁcient
for KvLQT1 modulation, and requires an additional, possibly associative interaction between the MinK transmem-
brane domain and KvLQT1. To identify the MinK subdomains necessary for gating modulation, deletion mutants
were designed and coexpressed with KvLQT1. A MinK construct with amino acid residues 94–129 deleted re-
tained the ability to modulate KvLQT1 gating, identifying the COOH-terminal region critical for gating modula-
tion. Finally, MinK/MiRP1 (MinK related protein-1) chimeras were generated to investigate the difference be-
tween these two closely related subunits in their ability to modulate KvLQT1. The results from this analysis indi-
cate that MiRP1 cannot modulate KvLQT1 due to differences within the transmembrane domain. Our results
allow us to identify the MinK subdomains that mediate KvLQT1 association and modulation.
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INTRODUCTION
 
The KCNE family is a group of small subunits that modu-
late voltage-gated potassium channels in heart, cochlea,
and small intestine. The ﬁrst identiﬁed member of the
KCNE family, MinK, a 129 amino acid protein with a sin-
gle putative transmembrane domain, was cloned origi-
nally from rat kidney and elicits a slowly activating potas-
 
sium current when expressed in 
 
Xenopus
 
 oocytes (Ta-
kumi et al., 1988). Eventually, it was discovered that
MinK interacts with and modulates a voltage-gated potas-
sium channel, KvLQT1 (Barhanin et al., 1996; San-
guinetti et al., 1996; Yang et al., 1997). In the heart, MinK
(KCNE1) coassembles with KvLQT1, forming functional
channels that produce the slowly activating cardiac potas-
 
sium current, I
 
Ks
 
, that is critical for myocardial repolar-
ization (Sanguinetti and Jurkiewicz, 1990). Mutations in
 
KvLQT1 and MinK are responsible for 
 
.
 
50% of congen-
ital long QT syndrome, an inherited cardiac disorder
characterized by syncope, arrhythmias, and sudden
death (Wang et al., 1996; Shalaby et al., 1997; Splawski et
al.
 
,
 
 1997). The second member of the KCNE family,
MinK related protein-1 (MiRP1),
 
1
 
 was cloned by homol-
ogy to MinK (Abbott et al.
 
,
 
 1999). MiRP1 appears to
coassemble with 
 
human ether-á-go-go–related gene
 
 (HERG)
in heart to produce the rapidly activating cardiac potas-
sium current I
 
Kr
 
, that also contributes to myocardial re-
polarization. MiRP1 does not modulate KvLQT1.
 
Previous work has been done to explore structure–
function relationships in MinK. Before cloning of
KvLQT1, mutagenesis experiments suggested that a
minimal MinK COOH-terminal sequence is essential
 
for the potassium channel activity observed in 
 
Xenopus
 
oocytes (Takumi et al., 1991). In another experiment,
synthetic peptides from a carboxy terminal region were
 
injected into oocytes, and I
 
Ks
 
-like currents were re-
corded, indicating that this region may be sufﬁcient for
potassium channel activity (Ben-Efraim et al.
 
,
 
 1996).
However, both studies relied upon the modulation of
 
an endogenous oocyte K
 
1
 
 channel. More recently,
 
Correspondence: Alfred L. George, Jr., Division of Genetic Medicine
451 MRB-II, Vanderbilt University Medical Center, Nashville, TN
37232-6304. Fax: 615-936-2661; E-mail al.george@vanderbilt.edu
 
1
 
Abbreviations used in this paper:
 
 aa, amino acid; HERG, 
 
human ether-á-
go-go–related gene
 
; MiRP1, MinK related protein-1. 
380
 
Functional Anatomy of MinK
 
Romey et al. (1997) demonstrated (using yeast two-
hybrid and immunodetection analysis) that the MinK
carboxy terminus may directly interact with the KvLQT1
pore-loop. No interaction with any other region of
MinK or KvLQT1 was detected (Romey et al.
 
,
 
 1997). Ex-
periments using scanning cysteine mutagenesis demon-
strated that cysteine substitution of amino acids within
the MinK transmembrane spanning domain rendered
I
 
Ks
 
 susceptible to partial block by external or internal
Cd
 
2
 
1
 
. The Cd
 
2
 
1
 
 block appeared to occur through a di-
rect pore blockade mechanism, suggesting that the
MinK transmembrane domain may be intimately associ-
ated with the KvLQT1 pore (Tai and Goldstein, 1998).
More recently, stilbenes and fenamates, small molecule
activators of the I
 
Ks
 
 channel complex, were found to
be dependent on the MinK amino terminus for their
pharmacological effect (Abitbol et al.
 
,
 
 1999). These ef-
forts have left many unanswered questions regarding
how MinK interacts with KvLQT1. Can one MinK subre-
gion be sufﬁcient for the various effects MinK has on
KvLQT1? If MinK is intimately associated with the
KvLQT1 pore, then which MinK domain is responsible
for subunit association? and what is its role in gating
modulation? Is there any role for the extracellular
amino terminus in KvLQT1 modulation? To modulate
gating and current amplitude, MinK presumably must
associate with KvLQT1 in a speciﬁc manner. Whether
MinK-mediated KvLQT1 association and modulation
involves one or many MinK subregions is unknown.
We have used chimeric and deletion analysis to sys-
tematically determine the structural requirements of
KvLQT1 modulation by MinK. We present evidence
that the MinK carboxyl terminus is necessary, but not
sufﬁcient, for KvLQT1 modulation and demonstrate
that gating modulation cannot occur without the MinK
transmembrane domain that appears critical for associ-
ation with KvLQT1. By contrast, we provide data indi-
cating that the MinK amino terminus is not necessary
for gating modulation. Furthermore, using chimeric
analysis between two members of the KCNE family, we
show that the MiRP1 COOH terminus can modulate
KvLQT1 in the presence of the MinK transmembrane
domain. These results suggest that the major func-
tional properties of MinK can be localized to two struc-
tural subdomains, and this knowledge may help eluci-
date the molecular mechanisms responsible for K
 
1
 
channel modulation.
 
MATERIALS AND METHODS
 
Construction of MinK Deletion Mutants
 
MinK deletion mutants were constructed using recombinant
polymerase chain reaction. A mutagenesis forward (sense)
primer complementary to MinK nucleotides 1–21 with a 5
 
9
 
 “tail”
containing a HindIII restriction site (5
 
9
 
-AGATCGATCAAGC-
CTATGCCCAGGATGATCCTGTCT-3
 
9
 
) was paired with various
 
reverse (antisense) primers contained 18–21 MinK nucleotides at
the desired region, followed by a stop codon and EcoRI restric-
tion site at the 5
 
9
 
 end (amino acids 67–130 deleted (MinK 
 
D
 
C-
term) 5
 
9
 
-TTATCAGAATTCTCATTAGCGGATGTAGCTCAGCAT-
3
 
9
 
, MinK 
 
D
 
94–129 5
 
9
 
-AGATCGATCGAATTCTCAGGCCTTGTC-
CTTCTCTTGCCA-3
 
9
 
, MinK 
 
D
 
79–129del 5
 
9
 
-AGATCGATCGAAT-
TCTCAGAATGGGTCGTTCGAGTGCT-3
 
9
 
). The MinK deletion
mutants were ampliﬁed via PCR from a human MinK cDNA tem-
plate, digested with HindIII and EcoRI, gel puriﬁed, and cloned
into the oocyte expression vector pSP64T. All sequences were
veriﬁed by automated sequencing.
 
Construction of 
 
b
 
1 Subunit/MinK Chimeras
 
The 
 
b
 
1 subunit/MinK chimeras were constructed using recombi-
nant PCR. For the 
 
b
 
1/MinK carboxy terminus chimera that en-
codes the 
 
b
 
1 amino terminus and transmembrane domain [amino
acids (aa) 1–182] in frame with the MinK carboxyl terminus (aa 67–
129, 
 
b
 
1/MinK1), an overlapping 
 
b
 
1/MinK forward primer (5
 
9
 
-ATT-
GTGGTGTTGACCATATGGCTCGTGGCAGAGATGATTTACT-
GCTACCGCTCCAAGAAGCTGGAGCA-3
 
9
 
) and a COOH-terminus
MinK reverse primer (5
 
9
 
-TCGATCGAATTCATGTAGGGGTCAT-
GGGGAAGGCTT3
 
9
 
) were used to amplify the MinK carboxyl ter-
minus from a human MinK cDNA template. The PCR ampliﬁed
fragment was digested with NdeI and EcoRI, gel puriﬁed, and
unidirectionally subcloned into pSP64T h
 
b
 
1. 
 
b
 
/MinK2 encodes
the 
 
b
 
1 amino terminus and the amino terminal half of the trans-
membrane domain (aa 1–171) in frame with the carboxyl termi-
nal half of the MinK transmembrane domain and the complete
MinK COOH terminus (aa 55–129). An overlapping 
 
b
 
1/MinK
forward primer (5
 
9
 
-GTGGTGTTGACCTGCTTCTTCACCCTG-
GGCATCAT-3
 
9
 
) and the COOH-terminus MinK reverse primer
were used to amplify the MinK sequence from a human MinK
cDNA template. The ampliﬁed region was digested with HincII and
EcoRI, gel puriﬁed, and unidirectionally subcloned into pSP64T
h
 
b
 
1. 
 
b
 
1/MinK-3 encodes the 
 
b
 
1 amino terminus (aa 1–160) fused
to the MinK transmembrane domain and carboxyl terminus (aa
44–129). To construct chimera 3, the 
 
b
 
1 amino terminus was
PCR ampliﬁed using a 
 
b
 
1 forward primer (5
 
9
 
-GATGAATA-
CAAGCTTGCTTGTTCT-3
 
9
 
) and an overlapping 
 
b
 
/MinK reverse
primer (5
 
9
 
-TACCATGAGGACGTAGAGGGCCTCAGACACGATG-
GATGCCAT-3
 
9
 
). In a separate PCR reaction, the MinK transmem-
brane domain and carboxy terminus were ampliﬁed using a for-
ward primer complementary to the MinK sequence present in
the overlapping 
 
b
 
/MinK reverse primer (5
 
9
 
-GCCCTCTACGTC-
CTCATGGTA-3
 
9
 
) and the MinK carboxy terminus reverse primer.
The PCR products of these two reactions were combined in a sub-
sequent PCR reaction, allowed to anneal, and then ampliﬁed us-
ing the 
 
b
 
1 forward primer and the MinK carboxy terminus reverse
primer. The resulting product was digested with HindIII and
EcoRI, gel puriﬁed, and cloned into pSP64T. All chimera se-
quences were veriﬁed by automated sequencing.
 
Construction of MiRP1/MinK Chimeras
 
MiRP1 was cloned from human genomic DNA using PCR. For-
ward (5
 
9
 
-AGATCGATCAAGCTTATCCCAGGATGTCTACTTTAT-
CCAATT-3
 
9
 
) and reverse (5
 
9
 
-GCTAGCTAGGAATTCTTGATGT-
TAGCTTGGTGCCTT-3
 
9
 
) primers based on the MiRP1 sequence
(GenBank Accession number: AF071002) were used to amplify a
441-bp fragment containing the complete coding sequence.
MiRP1 was then digested with HindIII and EcoRI, gel puriﬁed,
and cloned into the oocyte expression vector, pSP64T. MiRP1
function was veriﬁed by whole-cell voltage-clamp recording of oo-
cytes coexpressing HERG and MiRP1. The MiRP1/MinK chimera
containing the MiRP1 amino and transmembrane domain (aa
1–72) fused to the MinK carboxy terminus (aa 67–129, MiRP1/ 
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Cterm-MinK) was constructed using recombinant PCR. The
MiRP1 amino terminus and transmembrane domain were PCR
ampliﬁed using the MiRP1 forward primer and an overlapping
MiRP1/MinK reverse primer (5
 
9
 
-GTTCGAGTGCTCCAGCTTCT-
TGGAGCGCACAGTGCTCACCAGGAT-3
 
9
 
). The resulting prod-
uct was digested with HindIII and BstXI, gel puriﬁed, and unidi-
rectionally subcloned into pSP64TMinK. MinK/Cterm-MiRP1 en-
coding the MinK amino and transmembrane domain (aa 1–66)
fused to the MiRP1 carboxy terminus (aa 73–98) was designed us-
ing double overlap PCR. The MiRP1 carboxy terminus was PCR
ampliﬁed using a MinK/MiRP1 overlapping forward primer (5
 
9
 
-
ATCATGCTGAGCTACATCAAATCCAAGAGACGGGAA-5
 
9
 
) and
an MiRP1 carboxyl terminus reverse primer (5
 
9
 
-AGATCGATC-
GAATTCTCAGCTCTTGTACTTTTCCTGCCA-3
 
9
 
). In another
PCR reaction, the MinK amino and transmembrane domains were
ampliﬁed using the MinK forward primer and a reverse primer
complementary to the MinK region of the overlapping MinK/
MiRP1 forward primer. In a subsequent PCR reaction, the two
products were combined, allowed to anneal, and then ampliﬁed
using the MinK forward primer and the MiRP1 carboxy terminus
reverse primer. The resulting product was digested with HindIII
and EcoRI, gel puriﬁed, and cloned into pSP64T. The MiRP1 and
chimera sequences were veriﬁed using automated sequencing.
RNA from all constructs was transcribed in vitro from EcoRI-
linearized DNA template using Sp6 RNA polymerase, nucle-
otides, and solutions included in the mMessage machine in vitro
transcription kit (Ambion Corp.). RNA size and integrity were
evaluated by formaldehyde-agarose gel electrophoresis. RNA
concentrations were estimated by comparison with a 0.24–9.5-kb
RNA ladder (GIBCO BRL).
 
Oocyte Preparation and Injection
 
Oocytes were surgically removed from female 
 
Xenopus laevis
 
. Oo-
cytes were defolliculated using collagenase (2.0 mg/ml, 2 h) in
calcium-free ND-96 (for composition, see below). Stage V–VI oo-
cytes were injected with 46 nl of cRNA (cRNA concentration:
KvLQT1, 6 ng/oocyte; MinK constructs, 3 ng/oocyte) and incu-
bated at 18
 
8
 
C
 
 
 
in oocyte storage solution (ND-96 plus 50 mg gen-
tamicin and 275 mg pyruvic acid per liter for storage; pH 7.5).
 
Electrophysiology
 
Currents were recorded at room temperature 2–5 d after injec-
tion using two-microelectrode voltage-clamp technique with an
OC-725B ampliﬁer (Warner Instruments Corp.). Pipettes were
ﬁlled with 3 M KCl and had a 0.5–2 M
 
V
 
 resistance. Oocytes were
bathed in ND-96 containing (mM): 96 NaCl, 2 KCl, 1.8 CaCl
 
2
 
, 1
MgCl
 
2
 
, 5 HEPES, pH 7.5. For experiments in which HERG was
used, oocytes were bathed in a solution containing (mM): 96
KCl, 5 NaCl, 0.3 CaCl
 
2
 
, 1 MgCl
 
2
 
, 5 HEPES, pH 7.5. For Cd
 
2
 
1
 
 ex-
periments, a modiﬁed ND-96 solution in which NaCl was re-
placed isotonically with CdCl
 
2
 
 was used. Data were recorded us-
ing the PClamp 6 software program (Axon Instruments, Inc.).
Data were ﬁltered at 100 Hz and digitized at 1 kHz.
 
Data Analysis
 
Data were analyzed and plotted using a combination of pCLAMP
and Origin (Microcal Software) software. Normalized isochronal
voltage–activation relations were obtained by measuring current
at 2 s during depolarizing pulses between 
 
2
 
50 and 
 
1
 
60 mV from
a holding potential of 
 
2
 
80 mV. Data were ﬁt with a Boltzmann
function of the form: 1/{1 
 
1 
 
exp[(V 
 
2
 
 V
 
1/2
 
)/
 
k
 
v
 
]}, where V
 
1/2
 
 is
the half-maximal activation voltage and 
 
k
 
v
 
 is the slope factor.
Time constants of deactivation were determined by ﬁtting tail
 
currents with a single exponential equation: 
 
A
 
 * exp(
 
2
 
t
 
/
 
t
 
) 
 
1
 
 
 
C,
where A is an amplitude term, t is time, and C is a constant.
RESULTS
MinK modulates KvLQT1 gating by slowing activation
and removing inactivation. In addition, MinK changes
the rectiﬁcation of KvLQT1 currents, although the
mechanism of this is unclear. MinK also modulates
KvLQT1 current amplitude by an unknown mechanism
that may or may not be dependent on gating. Fig. 1 il-
lustrates the principle effects of MinK on coexpressed
KvLQT1 in Xenopus oocytes. Upon depolarization, oo-
cytes expressing KvLQT1 alone exhibit a rapidly activat-
ing, slowly deactivating outward potassium current with
characteristics similar to previously published data (Fig.
1 A, left; Barhanin et al., 1996; Sanguinetti et al., 1996).
KvLQT1 tail currents display a “hook,” indicating that
KvLQT1 inactivates to some extent (Fig. 1 B, left; Pusch
et al., 1998; Tristani-Firouzi and Sanguinetti, 1998).
KvLQT1-induced currents exhibit a linear current–volt-
age relationship from 240 to 160 mV (Fig. 1 C). MinK
dramatically modulates KvLQT1 gating, slowing activa-
tion (Fig. 1 A, right), removing inactivation (B, right),
and shifting the voltage dependence of activation to
more positive potentials (D). MinK-modulated currents
have three- to ﬁvefold greater current amplitudes than
KvLQT1 alone (Fig. 1 C). Understanding how MinK as-
sociates with KvLQT1 and identifying subregions in-
volved in gating modulation may provide insight into
the mechanism by which MinK modulates KvLQT1.
The MinK Carboxyl Terminus Is Necessary
for KvLQT1 Modulation
We used deletion analysis to determine the role of
MinK subdomains in mediating its effects on KvLQT1.
MinK can be divided into three subdomains: an extra-
cellular NH2 terminus, a transmembrane spanning seg-
ment, and an intracellular COOH terminus. Two natu-
rally occurring point mutations in the COOH terminus
have been linked to congenital long QT syndrome, sug-
gesting that this subdomain is functionally critical
(Splawski et al., 1997). Furthermore, Ben-Efraim et al.
(1996) injected synthetic peptide encoding a fragment
of the MinK COOH terminus (amino acid residues 67–
93) into Xenopus oocytes and recorded currents resem-
bling IKs, presumably by modulating an endogenous
KvLQT1. To determine whether the COOH terminus is
necessary for modulation, we coexpressed a COOH-ter-
minus deleted (MinK DCterm) MinK construct (deletion
of residues 67–129) and human KvLQT1 in Xenopus oo-
cytes. 3 d after cRNA injection, two-microelectrode volt-
age clamp was used to determine the phenotype of the
induced current. Coexpression of MinK DCterm and
KvLQT1 yielded a potassium current closely resem-
bling that of KvLQT1 alone (Fig. 2 A), although the382 Functional Anatomy of MinK
Figure 1. MinK Modulation of KvLQT1. (A)
Two-electrode voltage-clamp recordings from Xe-
nopus oocytes expressing either KvLQT1 (left) or
KvLQT11MinK (right). From a holding potential
of 280 mV, oocytes were depolarized for 2 s to
test potentials between 160 and 250 mV in 10-
mV steps, followed by repolarization to 270 mV
for 1 s. (B) Tail currents from oocytes expressing
either KvLQT1 (left) or KvLQT11MinK (right).
Tail currents were elicited by a 4-s 140-mV
prepulse, followed by repolarization to potentials
between 240 and 2100 mV in 10-mV steps. (C)
Current–voltage relationship for KvLQT1 or
KvLQT11MinK. Currents were recorded after 2-s
pulses at the given test potential. Error bars repre-
sent SEM (n 5 5). (D) Normalized isochronal (t 5
2 s) activation curve for ﬁve oocytes expressing ei-
ther KvLQT1 or KvLQT11MinK. The activation
curves were derived from currents elicited by the
activation protocol described in A. Experimental
data points were ﬁt with the equation 1/[1 1
exp(V 2 V1/2)/k], which gave the following ap-
parent V1/2 and slope factors: for KvLQT1: V1/2 5
227.4  6  1.1 mV, k 5 14.7 6 0.66; and for
KvLQT11MinK: V1/2app 5 29.4 6 1.7 mV, k 5
16.4 6 1.6. Error bars represent SEM. 
TABLE I
Activation and Deactivation Properties of KvLQT11MinK Chimera or MinK Mutant Channels
Channel V1/2app k tdeact
mV ms
KvLQT1 227.4 6 1.1* 14.7 6 0.7 468.9 6 37.7*
KvLQT11G55C MinKDCterm 216.6 6 0.5‡ 13.6 6 0.4 279.1 6 13.4‡
KvLQT11b1MinK1 228.9 6 1.5* 14.3 6 1.3 380.8 6 15.2*
KvLQT11b1MinK2 227.6 6 1.4* 16.8 6 1.1 612.9 6 48.2*
KvLQT11b1MinK3 30.6 6 1.7§ 22.2 6 0.4§ 695.8 6 88.1*
KvLQT11MinK CD79–129 18.4 6 1.5‡ 19.5 6 1.4 236.5 6 32.6‡
KvLQT11MinK CD94–129 29.4 6 1.2§ 14.0 6 1.1 349.4 6 28.6*
KvLQT11MiRP1/Cterm-MinK 233.6 6 1.9* 16.9 6 1.6 445.1 6 13.1*
KvLQT11MinK/Cterm-MiRP1 17.5 6 3.8‡ 23.4 6 2.0§ 187.3 6 8.3‡
KvLQT11MinK 29.4 6 1.7 16.5 6 1.6 1252.1 6 89.11§
*P , 0.001 compared with KvLQT11MinK, ‡P , 0.001 compared with KvLQT1 and KvLQT11MinK, §P , 0.001 compared with KvLQT1. V1/2 and slope
factors were derived as in Fig. 1 D. Time constants of deactivation (tdeact) at 270 mV were obtained as in Fig. 4 D. n $ 5 for each value.383 Tapper and George
voltage at which half the channels were open was
shifted 110 mV and the rate of deactivation was in-
creased (Table I).
To determine whether MinK DCterm was associated
with KvLQT1 despite the fact that little KvLQT1 modu-
lation was observed, we engineered a functional tag
into the MinK DCterm transmembrane domain. This
tag, a point mutation replacing glycine 55 with cysteine
(G55C), has been shown to confer susceptibility to par-
tial block by external Cd21 when coexpressed with
KvLQT1 in Xenopus oocytes (Tai and Goldstein, 1998).
Despite the absence of gating modulation, coexpres-
sion of G55C MinK DCterm rendered KvLQT1 currents
Cd21sensitive (Fig. 2 B, right). Exposing channels to
Cd21 for 15 min resulted in a 35% reduction in current
(Fig. 2 D). The time course of the current block ﬁt a
monoexponential function, as expected for a simple bi-
molecular reaction. Furthermore, current block by
Cd21 was fully reversible upon washout with ND-96
bath solution (Fig. 2 C). This effect of Cd21 was not due
to an interaction with an endogenous cysteine in
KvLQT1, as oocytes expressing KvLQT1 alone were not
Cd21 sensitive (Fig. 2 B, left).
Together, these data indicate that (a) the MinK
COOH terminus is necessary for KvLQT1 modulation,
and (b) an associative interaction between KvLQT1 and
either the MinK transmembrane domain or NH2 termi-
nus can occur in the absence of gating modulation.
Role of the MinK Transmembrane Region
in KvLQT1 Modulation
To test which MinK subregions were sufﬁcient for gat-
ing modulation, chimeras were constructed between
MinK and an unrelated protein, the sodium channel
b1 subunit. The b1 subunit was chosen as the MinK chi-
meric partner because it has a similar membrane topol-
ogy and its NH2 terminus is sufﬁcient for sodium chan-
nel modulation providing a functional assay for cell
surface expression. To determine whether the MinK
COOH terminus alone is sufﬁcient to modulate
KvLQT1, a chimera encoding the b1 NH2 terminus and
Figure 2. Coexpression of KvLQT1 and G55C
MinK DCterm. (A) Two-electrode voltage-clamp
recordings from Xenopus oocytes expressing ei-
ther KvLQT1 alone (left) or KvLQT11G55C
MinK DCterm. Currents were elicited as in Fig. 1
A. (B) Oocytes expressing KvLQT1 (left) or
KvLQT11G55C MinK DCterm (right) were ex-
posed externally to 0.5 mM Cd21 in ND-96 bath-
ing solution for 15 min during repetitive 10-s puls-
ing to 120 mV every 20 s. Representative tracings
are from the same oocyte before and after Cd21
exposure. (C) Time of onset and reversibility of
Cd21 block. Representative data from a typical ex-
periment, as described in B. Each data point rep-
resents steady state current at the end of a 10-s
pulse to 120 mV. The oocyte was continuously
perfused with Cd21 bathing solution beginning at
the time indicated by the arrow. Washout of Cd21
was performed by continuous perfusion of the
oocyte with ND-96 beginning at the time indi-
cated by the arrow. (D) Percentage of Cd21-
induced current block. Bar graph representation
of the percentage of current remaining after oo-
cytes expressing either KvLQT1 alone (left) or
KvLQT1 and G55C MinK DCterm (right) were
exposed to 0.5 mM Cd21 for 15 min. Data is aver-
aged for ﬁve experiments.384 Functional Anatomy of MinK
transmembrane domain (amino acid residues 1–182)
fused to the MinK COOH terminus (amino acid resi-
dues 67–129, b1/MinK1) was coexpressed in Xenopus
oocytes with KvLQT1. Upon depolarization, currents
recorded from cells expressing both KvLQT1 and b1/
MinK1 closely resembled those observed in oocytes ex-
pressing KvLQT1 alone (Fig. 3 A, left; Table I). In a sep-
arate group of oocytes, b1/MinK1 was coexpressed with
the human skeletal muscle sodium channel (hSkM1).
The resulting sodium currents exhibited more rapid in-
activation when compared with hSkM1 alone, demon-
strating that b1/MinK1 modulates hSkM1 and indicat-
ing that it was expressed at the plasma membrane (Fig.
3 A, right). Together, these results indicate that the
MinK COOH terminus is not sufﬁcient for KvLQT1
modulation.
Additional b1/Mink chimeras were used to investi-
gate the role of the MinK transmembrane domain in
KvLQT1 modulation. One chimera (b1/MinK2) con-
tained  b1 amino acid residues 1–171, encoding the NH2
terminus and half the transmembrane domain, fused to
MinK residues 55–129. Coexpressing b1/MinK2 with
KvLQT1 yielded currents that resembled KvLQT1 alone,
although activation was slightly slower (Fig. 3 B, left).
b1/MinK2 was able to modulate hSkM1, indicating that
it was properly targeted to the membrane (Fig. 3 B,
right). An additional b1/MinK chimera (b1/MinK3) en-
coded the b1 NH2 terminus (amino acid residues 1–160)
fused to the MinK transmembrane domain and COOH
terminus (amino acid residues 44–129). Coexpression of
b1/MinK3 with KvLQT1 resulted in currents nearly
identical to IKs, although the rate of deactivation was in-
creased compared with wild type (Fig. 3 C, left; Table I).
This result suggests that the MinK transmembrane do-
main and COOH terminus together are sufﬁcient to ex-
plain the predominant effects of MinK on KvLQT1,
while the NH2 terminus is not necessary for modulation.
Coexpression of the chimera with hSkM1 yielded a mod-
ulated sodium channel phenotype (Fig. 3 C, right), indi-
cating that the chimera was present at the cell surface
and supporting the idea that the b1 amino terminus is
sufﬁcient for hSkM1 modulation (Makita et al., 1996;
McCormick et al., 1999).
The results of the chimeric analysis indicate that the
MinK NH2 terminus is not necessary for KvLQT1 mod-
ulation, while the transmembrane domain is critical.
Our results, described above, demonstrating Cd21 sen-
sitivity of currents derived from KvLQT1 and G55C
MinK DCterm indicate that an associative interaction
between KvLQT1 and either the MinK NH2 terminus
or transmembrane domain occurs in the virtual ab-
sence of KvLQT1 modulation. This result combined
with our chimeric data strongly suggests that an impor-
tant interaction occurs between KvLQT1 and the MinK
transmembrane domain.
MinK Amino Acid Residues 67–93 Are Important
for KvLQT1 Gating Modulation
The MinK COOH terminus consists of 63 amino acid
residues. Previous data suggests that the ability of MinK
to modulate KvLQT1 resides in amino acid residues
67–93 (Takumi et al., 1991; Ben-Efraim et al., 1996).
We examined this by coexpressing a MinK deletion mu-
tant lacking amino acid residues 94–129 (MinK CD94-
129) with KvLQT1. The recorded currents illustrate
that MinK CD94–129 retains its modulatory effects on
KvLQT1 activation (Fig. 4 A, left center). The deletion
mutant, like wild-type MinK, also shifted the voltage de-
pendence of KvLQT1 activation to more positive po-
tentials (Fig. 4 B; Table I) and removed KvLQT1 inacti-
vation, as evident by the lack of a hooked tail current
(C). It was noted that KvLQT1/MinK CD94–129 chan-
nels had an increased rate of deactivation when com-
pared with channels formed by KvLQT1 and wild-type
MinK (Fig. 4 D; Table I). These results suggest that
MinK amino acid residues 94–129 are not necessary for
the majority of the MinK effects on KvLQT1 gating.
To further investigate the role of MinK amino acid
residues 67–93, an additional MinK deletion mutant
missing amino acids 79–129 was engineered (MinK
D79–129) and coexpressed with KvLQT1 in oocytes.
Upon depolarization, MinK D79–129 slowed KvLQT1
activation to a lesser extent than wild-type MinK (Fig. 4
A, right center). Additionally, MinK D79–129 shifted
the voltage dependence of KvLQT1 activation to more
positive potentials (Fig. 4 B; Table I), and removed
KvLQT1 inactivation (C) implicating the importance of
MinK amino acid residues 67–78 in KvLQT1 gating
modulation. Interestingly, like MinK D94–129, the rate
of KvLQT1/MinK D79–129 deactivation was also in-
creased compared with KvLQT1/wild-type MinK chan-
nels (Fig. 4 D; Table I).
A MinK/MiRP1 Chimera Modulates KvLQT1
MiRP1, like MinK, is a member of a family of small, sin-
gle transmembrane subunits that modulate voltage-
gated potassium channels. MiRP1 and MinK share 27%
amino acid identity overall and exhibit several clusters
of conserved residues within the transmembrane do-
main and COOH terminus. Despite these similarities,
when coexpressed with KvLQT1, MiRP1 has no effect
on gating or current amplitude (Abbott et al., 1999;
Fig. 5 B, left). However, MiRP1 does modulate HERG,
increasing the rate of deactivation while decreasing
current amplitude and shifting the voltage dependence
of activation to more positive voltages (Abbott et al.,
1999; Fig. 5 B, right). To determine whether MiRP1 as-
sociates with KvLQT1, but does not modulate due to
differences in the MiRP1 COOH terminus, a chimera
containing the MiRP1 NH2 terminus and transmem-385 Tapper and George
brane domain fused to the MinK COOH terminus
(MiRP1/Cterm-MinK) was engineered and coexpressed
with KvLQT1 in Xenopus oocytes.  The recorded cur-
rents exhibit a phenotype identical to that of KvLQT1
alone (Fig. 5 C, left; Table I), indicating that MiRP1/
Cterm-MinK either does not associate with and modu-
late KvLQT1 or that it is not expressed at the cell sur-
face. To determine whether MiRP1/Cterm-MinK is tar-
geted to the plasma membrane, we coexpressed MiRP1/
Cterm-MinK with HERG. MiRP1/Cterm-MinK modu-
lated HERG much like wild-type MiRP1 (Fig. 5 C, right),
suggesting that our chimera is indeed expressed and
that it cannot modulate KvLQT1. However, the converse
chimera containing the MinK NH2 terminus and trans-
membrane domain fused to MiRP1 amino acids 73–99
(MinK/Cterm-MiRP1), when coexpressed with KvLQT1
(Fig. 5 D, left), yielded a modulated phenotype, slow-
ing KvLQT1 activation, while also shifting the V1/2 and
increasing the rate of deactivation (Table I). Based on
the fact that the degree of modulation that occurs with
MinK/Cterm-MiRP1 is much more dramatic than the
degree of modulation seen with MinK DCterm (Fig. 2),
and that the COOH terminus of MiRP1 is quite similar
to that of MinK, we conclude that a signiﬁcant degree
of the gating modulation seen upon coexpression of
the chimera with KvLQT1 is due to the presence of
the MiRP1 COOH terminus. Interestingly, coexpres-
sion of MinK/Cterm-MiRP1 with HERG yielded cur-
rents closely resembling HERG alone (Fig. 5 D, right).
Based on our previous results that indicate the MinK
COOH terminus can modulate KvLQT1 only when an
interaction between KvLQT1 and the MinK transmem-
brane domain occurs, we conclude that MiRP1 does
not modulate KvLQT1; in part because of differences
in the transmembrane domain that mediate KvLQT1
association. This conclusion supports the idea that two
MinK subregions mediate association and modulation
of KvLQT1.
Figure 3. Effects of b/MinK chimeras on
KvLQT1 and hSkM1. (A) Two-electrode voltage-
clamp recordings from Xenopus oocytes express-
ing either KvLQT1 (left) or hSkM1 (right) and
b/MinK1. Currents from oocytes coexpressing the
chimera and KvLQT1 were elicited by a 1-s pulse
to potentials between 160 and 250 mV in 10-mV
steps, followed by repolarization to 270 mV for
1 s. Oocytes were held at 280 mV. Currents re-
corded from oocytes coexpressing hSkM1 and the
chimera were elicited by 30-ms pulses to voltages
between 280 and 110 mV from a holding poten-
tial of 2120 mV. (B) Oocytes coexpressing
KvLQT1 or hSkM1 and b/MinK2. The activation
protocol used was the same as in A. (C) Oocytes
coexpressing KvLQT1 or hSkM1 and b/MinK3.
The KvLQT1 activation protocol was the same as
the protocol used in A, except depolarizing pulses
were 2 s. The hSKM1 activation protocol was the
same as in A. (D) Oocytes coexpressing KvLQT1
or hSkM1 and MinK. Activation protocols were
the same as in C. Icons represent the proposed
membrane topology of MinK and the chimeras.
Filled boxes and lines represent MinK regions;
open boxes and lines represent b1 regions.386 Functional Anatomy of MinK
DISCUSSION
In this study, we used deletion analysis and chimeras to
identify the MinK subdomains involved in KvLQT1
modulation. MinK has multiple effects on KvLQT1 gat-
ing, including slowing of activation, shifting the voltage
dependence of activation to more positive potentials,
and removal of inactivation. MinK increases current
amplitude three- to ﬁvefold when coexpressed with
KvLQT1. Finally, for modulation to occur, MinK must
presumably associate with KvLQT1, but it was previ-
ously unknown whether this involves the same or differ-
ent structures responsible for the gating and current
amplitude effects. Here, we present data identifying
which Mink subdomains are responsible for association
with and gating of KvLQT1.
The results from our deletion analysis and chimeras
indicate that the MinK COOH terminus is necessary
but not sufﬁcient for KvLQT1 modulation. Our experi-
ments using MinK/b1 chimeras lacking a complete
MinK transmembrane domain demonstrate that the
MinK COOH terminus does not modulate KvLQT1 in
the absence of the MinK transmembrane domain, even
though the subdomains reach the plasma membrane.
These data indicate that the COOH terminus is not suf-
ﬁcient for modulation and that subunit association re-
quires the MinK transmembrane domain. This associa-
tive interaction involving the transmembrane domain
may serve to localize the MinK COOH terminus to a re-
gion of KvLQT1 that is involved directly or indirectly in
the modulation process. In addition to association, the
Figure 4. Effects of MinK deletion mutants on KvLQT1. (A) Voltage-clamp recordings of Xenopus oocytes expressing (from left to right)
KvLQT11MinK, KvLQT11MinK CD94–129, KvLQT11MinK CD79–129, or KvLQT1 alone. Activation protocol was the same as in Fig. 1.
Icons represent MinK with the last amino acid indicated. (B) Normalized isochronal (t 5 2 s) activation curve for KvLQT1, KvLQT11MinK,
KvLQT11MinKCD94–129, and KvLQT1MinK CD79–129. Experimental data points were ﬁt with the function 1/[1 1 exp(V 2 V1/2)/k],
which gave the following apparent V1/2 and slope factors: KvLQT11MinK: V1/2app 5 29.4 6 1.6 mV, k 5 16.4 6 1.6; KvLQT11MinK CD94–
129: V1/2app 5 29.3 6 1.2 mV, k 5 14.0 6 1.1; KvLQT11MinK CD79–129: V1/2app 5 18.4 6 1.5 mV, k 5 19.5 6 1.4 (n 5 5). Error bars repre-
sent SEM. (C) Representative tail current tracings from oocytes expressing KvLQT1 (top, left), KvLQT11MinK (top right), KvLQT11MinK
CD94–129 (bottom left), and KvLQT11MinK CD79–129 (bottom right). Tail currents were elicited by a 4-s 140-mV prepulse, followed by
repolarization to 270 mV. (D) Voltage dependence of deactivation time constants for KvLQT1, KvLQT11MinK, KvLQT11MinK CD94–
129, and KvLQT11MinK CD79–129. Time constants were determined from a monoexponential ﬁt of tail currents elicited via the deactiva-
tion protocol used in Fig. 1. For KvLQT11MinK and KvLQT11MinK deletion mutants, tail currents were ﬁt over a 2-s interval immediately
after repolarization. For KvLQT1, tail currents were ﬁt starting at the peak of the tail current hook (n 5 5). Error bars represent SEM.387 Tapper and George
MinK transmembrane domain may also play a direct
role in gating modulation, although this is clearly de-
pendent on the MinK COOH terminus since, in the ab-
sence of the COOH terminus, little gating modulation
is observed (Fig. 2 A, Table I). Supporting this idea, Ta-
kumi et al. (1991), using amino acid substitution, de-
termined that a single point mutation within the MinK
transmembrane domain, L52I, altered gating modula-
tion of the KvLQT1 present in Xenopus oocytes. In addi-
tion, a mutation in the MinK transmembrane domain
associated with long QT syndrome has been found to
alter MinK-mediated KvLQT1 gating modulation (see
below). Whether these two transmembrane domain
mutations alter gating modulation because they are di-
rectly involved in gating or because the mutations alter
protein conformation so that the MinK COOH termi-
nus is not in the proper orientation to modulate
KvLQT1 is unknown and requires further study. A re-
cent report indicates that small molecule activators of
the IKs complex, namely stilbenes and fenamates, medi-
ate their pharmacological effects through the MinK
NH2 terminus. Interestingly, the results from our exper-
iments indicate that the MinK NH2 terminus is not nec-
essary for KvLQT1 modulation, although this does not
rule out the possibility that this region is important for
pharmacological phenomena.
The mechanism by which MinK modulates KvLQT1
gating is currently unknown. Our MinK COOH-termi-
nal deletion analysis indicates that the critical MinK re-
gion involved in gating modulation resides within
amino acid residues 67–93. A MinK deletion mutant
with amino acids 94–129 deleted was able to slow
KvLQT1 activation, shift the voltage dependence of ac-
tivation to more positive potentials, and remove inacti-
vation. An additional deletion mutant containing only
12 COOH-terminal amino acids (residues 67–78) shifts
the voltage dependence of activation to more positive
potentials, removes inactivation, and partially slows ac-
tivation. From these results, we conclude that when as-
sociated with KvLQT1 and fused to the MinK trans-
Figure 5. Effects of MinK/MiRP1 chimeras on
KvLQT1. (A) Whole-cell voltage-clamp recording
of Xenopus oocyte expressing either KvLQT1 (left)
or HERG (right). For oocytes expressing KvLQT1,
currents were elicited by the activation protocol
described in Fig. 1 A. Oocytes were bathed in ND-
96. For oocytes expressing HERG, currents were
elicited by 3-s depolarizing pulses from 140 to
270 mV in 10-mV steps, followed by repolariza-
tion to 280 mV for 6 s. For all HERG experi-
ments, oocytes were bathed in 95 mM KCl. (B)
Oocytes expressing either KvLQT1 (left) or
HERG (right) with MiRP1. Activation protocols
were the same as in A. (C) Oocytes expressing ei-
ther KvLQT1 (left) or HERG (right) with MiRP1/
Cterm-MinK. Activation protocols were the same
as in A. (D) Oocytes expressing either KvLQT1
(left) or HERG (right) with MinK/Cterm-MiRP1
(right). Activation protocol was the same as in A.
Icons represent predicted topology of the chime-
ras. Filled boxes and lines represent MinK regions;
open boxes and lines represent MiRP1 regions.388 Functional Anatomy of MinK
membrane domain, MinK amino acid residues 67–93
are critical for gating modulation. It will be interesting
to determine how this small region of the MinK COOH
terminus exerts it effects on KvLQT1.
Eight naturally occurring point mutations in MinK
have been discovered and linked to congenital long QT
syndrome, ﬁve of which have been characterized func-
tionally (Bianchi et al., 1999; Schulze-Bahr et al., 1997;
Splawski et al., 1997; Tyson et al., 1997; Duggal et al.,
1998). Three of the mutations, S74L, D76N, and W87R
are localized to the MinK COOH-terminal region that
we have found to be critical for KvLQT1 gating modu-
lation. These three mutants confer altered gating prop-
erties to KvLQT1, which is consistent with our results
(Splawski et al., 1997; Bianchi et al., 1999). The two
other MinK mutants, V47F and L51H, reside in the
transmembrane domain. V47F MinK shifts the KvLQT1
voltage dependence of activation to more positive po-
tentials compared with wild-type (Bianchi et al., 1999).
In agreement with this ﬁnding, our results indicate that
the transmembrane domain may play a role in altering
KvLQT1 voltage dependence of activation since coex-
pression of KvLQT1 with MinK DCOOH term did shift
the KvLQT1 voltage dependence of activation to more
positive potentials compared with KvLQT1 alone. Co-
expression of L51H MinK with KvLQT1 yields currents
closely resembling KvLQT1 alone. Immunohistochemi-
cal analysis indicated that this is due to the fact that
L51H MinK is not expressed at the cell surface, per-
haps because it is misfolded or improperly targeted (Bi-
anchi et al., 1999).
To date, three of ﬁve KCNE family members have
been functionally characterized. MinK and MiRP2 both
coassemble with KvLQT1, while MiRP1 forms channels
with HERG (Barhanin et al., 1996; Sanguinetti et al.,
1996; Abbott et al., 1999; Schroeder et al., 2000). Inter-
estingly, these three family members share the most
similarity within regions that we have identiﬁed as im-
portant for subunit association and gating modulation.
Our chimera experiments indicate that MiRP1 cannot
modulate KvLQT1 due to a difference in the trans-
membrane domain. A chimera containing the MinK
COOH terminus in a MiRP1 background does not
modulate KvLQT1, presumably because the associative
interaction, as well as any interaction important for gat-
ing modulation that normally occurs between KvLQT1
and the MinK transmembrane domain, is not present.
The converse chimera consisting of the MiRP1 COOH
terminus in a MinK background does modulate
KvLQT1, suggesting that the MiRP1 COOH terminus
can modulate KvLQT1 gating in concert with the MinK
transmembrane domain. Together, these results sup-
port our conclusion that the transmembrane domain is
critical for subunit association and is important for gat-
ing modulation when fused to the COOH terminus. In
addition, these results provide evidence that other
KCNE members may associate with and modulate other
K1 channels through analogous subdomains.
In summary, we have identiﬁed the MinK subdo-
mains responsible for KvLQT1 gating modulation and
subunit association. How and where these subregions
interact with KvLQT1 is unknown, but presents an in-
teresting and important question.
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